newsfilter
← Latest News
Business Wire·

Akili Reports Second Quarter 2023 Financial Results and Provides Business Update

EndeavorRxⓇ prescriptions in pediatric ADHD market grew 27% in Q2 2023 over Q1 2023 Company is preparing FDA submission for EndeavorOTCTM as over-the-counter treatment, following its June 2023 product release in the